Specifically, NF-κB activation, which is frequently observed in breast cancer, promotes the development of a hormone-independent and invasive breast cancer phenotype [7], whereas its inhibition reverses endocrine resistance [4]. This evidence concerns the gene NFKB1 and breast carcinoma.